Sarah Joanne Williams

Principal Accounting Officer, AN2 Therapeutics, Inc.

Companies

AN2 Therapeutics, Inc.Principal Accounting Officer Feb 3, 2026 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

AN2 Therapeutics, Inc. ANTX66,311 shares²$216.8K at $3.27Sep 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 1, 2026Sold 272 shares at $5.53 of AN2 Therapeutics, Inc.²
May 29, 2026Sold 265 shares at $4.43 of AN2 Therapeutics, Inc.³
Mar 3, 2026Sold 327 shares at $1.06 of AN2 Therapeutics, Inc.⁴
Feb 20, 2026Granted 48,375 shares of AN2 Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAN2 Therapeutics, Inc., Principal Accounting Officer
2
SEC EDGARAN2 Therapeutics, Inc. shares after the filing of Sep 1, 2026
3
SEC EDGARForm 4 filed Jun 2, 2026
4
SEC EDGARForm 4 filed Mar 5, 2026
5
SEC EDGARForm 4 filed Feb 23, 2026